Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Axim Biotechnologies (AXIM)

Axim Biotechnologies (AXIM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
AXIM(R) Biotechnologies Applies for FDA Emergency Use Approval (EUA) for High Throughput, Patent-Pending Neutralizing Antibody Diagnostic Test for COVID-19

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announced today the...

AXIM : 0.8200 (+1.25%)
AXIM(R) Biotechnologies Releases Rapid NeuCovix(TM) Test Results Showing Strong Agreement with COVID-19-Based Neutralization Tests

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announces the completion...

AXIM : 0.8200 (+1.25%)
AXIM(R) Biotechnologies Welcomes Former Secretary of Veterans Affairs Peter O'Rourke to Company's Board of Directors

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announced today it has...

AXIM : 0.8200 (+1.25%)
Medical Marijuana, Inc. Investment Company AXIM(R) Biotechnologies Unveils World's First COVID-19 Rapid Diagnostic Test for Neutralizing Antibodies and Files Pre-Emergency Use Authorization

via NEWMEDIAWIRE -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical...

MJNA : 0.0143 (+1.42%)
AXIM : 0.8200 (+1.25%)
AXIM(R) Biotechnologies Unveils First-in-Class COVID-19 Rapid Diagnostic Test for Neutralizing Antibodies and Files Pre-Emergency Use Authorization with the FDA

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological research, today announced the development of...

AXIM : 0.8200 (+1.25%)
AXIM(R) Biotechnologies Appoints Dr. Alim Seit-Nebi as Chief Technology Officer of Subsidiary Sapphire Biotech

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological research, announced today it has appointed...

AXIM : 0.8200 (+1.25%)
AXIM(R) Biotechnologies Begins Pre-Clinical Pharmacokinetic Animal Drug Studies on its Cancer Drug Compound SPX-1009

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological research, announced today that its subsidiary...

AXIM : 0.8200 (+1.25%)
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Expands Research Division and Announces Dr. Sergei Svarovsky as Chief Scientific Officer of Subsidiary Sapphire Biotech

, /PRNewswire/ --  (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands...

MJNA : 0.0143 (+1.42%)
AXIM : 0.8200 (+1.25%)
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Expands Research Division and Announces Dr. Sergei Svarovsky as Chief Scientific Officer of Subsidiary Sapphire Biotech

SAN DIEGO , May 28, 2020 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched...

AXIM : 0.8200 (+1.25%)
MJNA : 0.0143 (+1.42%)
AXIM(R) Biotechnologies Expands Research Division and Announces Dr. Sergei Svarovsky as Chief Scientific Officer of Subsidiary Sapphire Biotech

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and cannabinoid research, announced today it...

AXIM : 0.8200 (+1.25%)
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files Patent for Unique Early Detection Cancer Biomarker

, /PRNewswire/ --  (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands...

HEMP : 0.0055 (+7.84%)
MJNA : 0.0143 (+1.42%)
AXIM : 0.8200 (+1.25%)
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files Patent for Unique Early Detection Cancer Biomarker

SAN DIEGO , May 21, 2020 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched...

MJNA : 0.0143 (+1.42%)
AXIM : 0.8200 (+1.25%)
AXIM(R) Biotechnologies Files for Patent for Unique Biomarker for Early Detection of Cancer in Blood

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and cannabinoid research, announced today its...

AXIM : 0.8200 (+1.25%)
AXIM(R) Biotechnologies Issues Update Letter to Shareholders

AXIMBiotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and cannabinoid research, announced today that...

AXIM : 0.8200 (+1.25%)
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files New U.S. Patent Application for Water-Soluble Cannabinoid Molecules

, /PRNewswire/ --  (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands...

MJNA : 0.0143 (+1.42%)
AXIM : 0.8200 (+1.25%)
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files New U.S. Patent Application for Water-Soluble Cannabinoid Molecules

SAN DIEGO , May 5, 2020 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's...

AXIM : 0.8200 (+1.25%)
MJNA : 0.0143 (+1.42%)
AXIM(R) Biotechnologies Files New U.S. Patent Application for Water-Soluble Cannabinoid Molecules

AXIM(R) Biotechnologies, Inc. (OTC: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and cannabinoid research, announced today that...

AXIM : 0.8200 (+1.25%)
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Receives New U.S. Patent Issuance for Chewing Gum Comprising Cannabinoids and Nicotine

Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands...

MJNA : 0.0143 (+1.42%)
AXIM : 0.8200 (+1.25%)
AXIM(R) Biotechnologies Receives New U.S. Patent Issuance for Chewing Gum Comprising Cannabinoids and Nicotine to Treat or Alleviate Tobacco Smoking

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and cannabinoid research, announced today the...

AXIM : 0.8200 (+1.25%)
AXIM(R) Biotechnologies Completes Pre-Clinical Drug Studies on New Compound Proving Tenfold Greater Inhibition of Tumor Metastasis Than Parent Compound

AXIMBiotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and cannabinoid research, announced today that...

AXIM : 0.8200 (+1.25%)

Van Meerten Stock Picks

The 5 Best MidCaps
I wanted to find the 5 Mid Caps that have had the best momentum over the past year so I used Barchart to sort the S&P 400 MidCap Stock Index for the stocks with the highest Weighted Alpha and technical buying signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar